187 related articles for article (PubMed ID: 18541656)
1. A novel immunoprecipitation strategy identifies a unique functional mimic of the glial cell line-derived neurotrophic factor family ligands in the pathogen Trypanosoma cruzi.
Lu B; PereiraPerrin M
Infect Immun; 2008 Aug; 76(8):3530-8. PubMed ID: 18541656
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma cruzi promotes neuronal and glial cell survival through the neurotrophic receptor TrkC.
Weinkauf C; Pereiraperrin M
Infect Immun; 2009 Apr; 77(4):1368-75. PubMed ID: 19179422
[TBL] [Abstract][Full Text] [Related]
3. Molecular mimicry between Trypanosoma cruzi and host nervous tissues.
Avila JL
Acta Cient Venez; 1992; 43(6):330-40. PubMed ID: 1343745
[TBL] [Abstract][Full Text] [Related]
4. Functional mapping of receptor specificity domains of glial cell line-derived neurotrophic factor (GDNF) family ligands and production of GFRalpha1 RET-specific agonists.
Baloh RH; Tansey MG; Johnson EM; Milbrandt J
J Biol Chem; 2000 Feb; 275(5):3412-20. PubMed ID: 10652334
[TBL] [Abstract][Full Text] [Related]
5. Structural studies of GDNF family ligands with their receptors-Insights into ligand recognition and activation of receptor tyrosine kinase RET.
Wang X
Biochim Biophys Acta; 2013 Oct; 1834(10):2205-12. PubMed ID: 23085183
[TBL] [Abstract][Full Text] [Related]
6. Small Molecules and Peptides Targeting Glial Cell Line-Derived Neurotrophic Factor Receptors for the Treatment of Neurodegeneration.
Sidorova YA; Saarma M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911810
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma cruzi glutathione-binding proteins: immunogenicity during human and experimental Chagas' disease.
Plumas-Marty B; Verwaerde C; Loyens M; Velge P; Taibi A; Cesbron MF; Capron A; Ouaissi MA
Parasitology; 1992 Feb; 104 Pt 1():87-98. PubMed ID: 1614743
[TBL] [Abstract][Full Text] [Related]
8. The MASP family of Trypanosoma cruzi: changes in gene expression and antigenic profile during the acute phase of experimental infection.
dos Santos SL; Freitas LM; Lobo FP; Rodrigues-Luiz GF; Mendes TA; Oliveira AC; Andrade LO; Chiari E; Gazzinelli RT; Teixeira SM; Fujiwara RT; Bartholomeu DC
PLoS Negl Trop Dis; 2012; 6(8):e1779. PubMed ID: 22905275
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning of a Trypanosoma cruzi cell surface casein kinase II substrate, Tc-1, involved in cellular infection.
Augustine SA; Kleshchenko YY; Nde PN; Pratap S; Ager EA; Burns JM; Lima MF; Villalta F
Infect Immun; 2006 Jul; 74(7):3922-9. PubMed ID: 16790765
[TBL] [Abstract][Full Text] [Related]
10. Novel RET agonist for the treatment of experimental neuropathies.
Viisanen H; Nuotio U; Kambur O; Mahato AK; Jokinen V; Lilius T; Li W; Santos HA; Karelson M; Rauhala P; Kalso E; Sidorova YA
Mol Pain; 2020; 16():1744806920950866. PubMed ID: 32811276
[TBL] [Abstract][Full Text] [Related]
11. Trypanosoma cruzi: polypeptide markers of epimastigotes and trypomastigotes.
Rangel-Aldao R; Comach G; Allende O; Cayama E; Delgado V; Piras R; Piras M; Henriquez D; Negri S
Mol Biochem Parasitol; 1986 Jul; 20(1):25-32. PubMed ID: 3090434
[TBL] [Abstract][Full Text] [Related]
12. Glial cell line-derived neurotrophic factors (GFLs) and small molecules targeting RET receptor for the treatment of pain and Parkinson's disease.
Mahato AK; Sidorova YA
Cell Tissue Res; 2020 Oct; 382(1):147-160. PubMed ID: 32556722
[TBL] [Abstract][Full Text] [Related]
13. Purification of a Trypanosoma cruzi trypomastigote 60-kilodalton surface glycoprotein that primes and activates murine lymphocytes.
Villalta F; Lima MF; Howard SA; Zhou L; Ruiz-Ruano A
Infect Immun; 1992 Aug; 60(8):3025-32. PubMed ID: 1639469
[TBL] [Abstract][Full Text] [Related]
14. Identification and isolation of Trypanosoma cruzi trypomastigote cell surface protein with properties expected of a fibronectin receptor.
Ouaissi MA; Cornette J; Capron A
Mol Biochem Parasitol; 1986 Jun; 19(3):201-11. PubMed ID: 3526144
[TBL] [Abstract][Full Text] [Related]
15. Comparison of chagasic and non-chagasic myocardiopathies by ELISA and immunoblotting with antigens of Trypanosoma cruzi and Trypanosoma rangeli.
O'Daly JA; Carrasco H; Fernandez V; Rodríguez MB
Acta Trop; 1994 Apr; 56(4):265-87. PubMed ID: 8023751
[TBL] [Abstract][Full Text] [Related]
16. Trypanosoma cruzi tubulin eliminated in the urine of the infected host.
Bertot GM; Corral RS; Fresno M; Rodríguez C; Katzin AM; Grinstein S
J Parasitol; 1998 Jun; 84(3):608-14. PubMed ID: 9645865
[TBL] [Abstract][Full Text] [Related]
17. [Partial purification and use of Trypanosoma cruzi glycosidic fractions for Chagas disease diagnosis].
De Lima Rivero AR; Farías Tamoy MN; Tortolero Leal E; Navarro Aguilera MC; Contreras Alvarez VT
Acta Cient Venez; 2001; 52(4):235-47. PubMed ID: 11915441
[TBL] [Abstract][Full Text] [Related]
18. Characterization of major surface and excretory-secretory immunogens of Trypanosoma cruzi trypomastigotes and identification of potential protective antigen.
Ouaissi MA; Taibi A; Cornette J; Velge P; Marty B; Loyens M; Esteva M; Rizvi FS; Capron A
Parasitology; 1990 Feb; 100 Pt 1():115-24. PubMed ID: 2107503
[TBL] [Abstract][Full Text] [Related]
19. Effect of Trypanosoma cruzi released antigens binding to non-infected cells on anti-parasite antibody recognition and expression of extracellular matrix components.
Pinho RT; Vannier-Santos MA; Alves CR; Marino AP; Castello Branco LR; Lannes-Vieira J
Acta Trop; 2002 Aug; 83(2):103-15. PubMed ID: 12088851
[TBL] [Abstract][Full Text] [Related]
20. Correlation of tunicamycin-sensitive surface glycoproteins from Trypanosoma cruzi with parasite interiorization into mammalian cells.
Zingales B; Katzin AM; Arruda MV; Colli W
Mol Biochem Parasitol; 1985 Jun; 16(1):21-34. PubMed ID: 3929084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
